Table 4 Characteristics of prostate cancer patients by hospitals

Mean age ± SD

72.6 ± 6.1

66.9 ± 7.7

67.3 ± 5.6

67.8 ± 6.7

67.1 ± 7.8

66.2 ± 6.9

67.6 ± 9.2

Missing (%):

0.0

2.2

0.0

5.1

0.0

6.1

4.1

Mean BMI ± SD

28.2 ± 5.7

27.3 ± 3.5

27.6 ± 3.8

28.8 ± 6.4

28.9 ± 4.1

27.6 ± 4.3

27.2 ± 2.9

Missing (%):

0.0

4.4

0.0

3.8

0.9

21.2

4.1

Median PSA (ng/mL) ± IQR

10.4 ± 15.5

5.7 ± 3.4

6.7 ± 3.7

7.8 ± 7.7

8.6 ± 12.2

7.0 ± 3.8

8.7 ± 8.2

Missing (%):

2.1

8.8

0.0

6.4

0.0

3.0

1.4

ECOG WHO (%)

Fully active:

72.9

84.6

91.9

71.8

69.6

63.6

75.3

Restricted or worse:

25.0

15.4

8.1

23.1

30.4

33.3

17.8

Missing:

2.1

0.0

0.0

5.1

0.0

3.0

6.8

Primary tumour clinical stage (T) (%)

Tx:

0.0

0.0

0.0

1.3

1.3

0.0

0.0

T1a-c

45.8

45.1

16.2

37.2

37.2

43.8

41.1

T2a-c:

43.8

39.6

56.8

37.2

37.2

33.0

19.3

T3a-b :

6.3

14.3

21.6

20.5

20.5

22.3

6.8

T4:

4.1

1.0

0.0

3.8

3.8

0.9

1.4

Missing:

0.0

0.0

5.4

0.0

0.0

0.0

1.4

Regional lymph nodes clinical stage (N) (%)

Nx-N0:

100.0

98.9

100.0

92.3

100.0

100.0

97.3

N1:

0.0

1.1

0.0

7.7

0.0

0.0

2.7

Missing:

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Distance metastasis clinical stage (M) (%)

Mx-M0:

95.8

100.0

100.0

93.6

98.2

100.0

98.6

M1a-c:

4.2

0.0

0.0

6.4

1.8

0.0

1.4

Missing:

0.0

0.0

0.0

0.0

0.0

0.0

0.0

D’Amico Classification (%)

Low risk:

14.6

50.5

54.1

32.1

39.3

36.4

21.9

Medium risk:

27.1

12.1

29.7

17.9

23.2

45.5

34.2

High risk:

58.3

37.4

16.2

50.0

37.5

18.1

42.5

Missing:

0.0

0.0

0.0

0.0

0.0

0.0

1.4

Total Gleason (%)

2-6:

16.7

73.6

64.9

68.0

66.9

36.4

31.5

7:

29.2

19.8

29.7

17.9

18.8

51.5

43.8

>7:

54.1

6.6

2.7

10.2

14.3

9.1

19.2

Missing:

0.0

0.0

2.7

3.9

0.0

3.0

5.5

Median total Gleason ± IQR

8.0 ± 1.0

6.0 ± 1.0

6.0 ± 1.0

6.0 ± 2.0

6.0 ± 1.0

7.0 ± 1.0

7.0 ± 1.0

Median time between first consultation and diagnosis in days ± IQR

99.5 ± 139.0

79.0 ± 211.0

110.0 ± 117.0

78.5 ± 107.3

92.0 ± 99.0

133.0 ± 195.0

76.5 ± 100.0

Missing (%):

0.0

3.3

5.4

7.7

4.5

6.1

1.4

Median time between diagnosis and first treatment in days ± IQR

30.5 ± 127.5

78.0 ± 62.0

83.0 ± 72.0

104.0 ± 70.5

55.0 ± 66.5

73.5 ± 84.5

70.0 ± 95.0

Missing (%):

0.0

4.4

0.0

1.3

6.3

3.0

2.7

Median time between first consultation and first treatment in days ± IQR

164.0 ± 232.0

154.0 ± 207.0

212.0 ± 165.0

200.0 ± 130.0

166.0 ± 112.8

203.0 ± 149.8

165.0 ± 128.5

Missing (%):

0.0

6.6

5.4

9.0

8.9

9.1

4.1